Investor Alert: Lexaria Bioscience - The Modern Way to Improve Oral Drugs
Lexaria Bioscience began developing DehydraTECH in 2014. Since then, they have strengthened and broadened the technology to an unprecedented degree. T …
Demonstrated Early-Stage Effectiveness
Lexaria Bioscience began developing DehydraTECH in 2014. Since then, they have strengthened and broadened the technology to an unprecedented degree. They are a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs.
DehydraTECH
DehydraTECH is one of the world's newest technologies designed to improve the efficacy of orally administered bioactive molecules. That includes; anti-viral drugs, nicotine, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, and other molecules.
Additionally, DehydraTECH increases bio-absorption by up to 5x, reduces the time of onset from up to 1 – 2 hours to just minutes, masks unwanted tastes, and can reduce unwanted side effects by enabling lower overall dosing.
For more information on Lexaria Bioscience (NASDAQ: LEXX) please click the request investor info button.
Latest Articles
.png)
Hot Companies
You might also like
Southern Silver: Is Cerro Las Minitas Emerging as a Major Silver Project?
Southern Silver is advancing its flagship Cerro Las Minitas silver-lead-zinc project in Mexico, which management describes as one of the larger, higher-grade silver-based projects globally.
CEO Clip - Southern Silver: Can a Growing Silver Resource Support a Major Underground Mine in Mexico?
Southern Silver is advancing the Cerro Las Minitas silver-lead-zinc project in Durango, Mexico, where additional drilling is being incorporated into an updated mineral resource estimate and Preliminary Economic Assessment.
